Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Katherine K MatthayJ N Lukens

Abstract

To identify a biologically favorable and unfavorable subset of patients with Evans stage III neuroblastoma and to determine whether treatment stratification would improve the event-free survival (EFS) for high-risk patients and maintain excellent EFS for the lower-risk patients. Risk stratification was performed by age, MYCN gene copy number, Shimada histopathologic classification, and serum ferritin level. Lower-risk patients were treated on the less intensive Children's Cancer Group (CCG)-3881, whereas high-risk patients were treated on CCG-3891, which included more intensive multimodality therapy and, in some cases, autologous bone marrow transplantation (ABMT). Of 228 Evans stage III patients entered onto the study, 92% also met the definition of International Neuroblastoma Staging System (INSS) stage 3. One hundred forty-three patients met the lower-risk criteria, which included 89 patients less than 1 year of age and 54 patients 1 year of age or greater, and favorable biology, whereas 85 patients were 1 year of age or greater and biologically unfavorable. Biologically unfavorable patients 1 year of age or greater who underwent gross surgical resection had improved survival, whereas the outcome of infants or biologically f...Continue Reading

Citations

Jun 11, 1999·Journal of Pediatric Hematology/oncology·S G DuBoisK K Matthay
Feb 16, 1999·Seminars in Surgical Oncology·G M HaaseJ B Atkinson
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L SchmidtK K Matthay
Mar 15, 2000·Annals of Tropical Paediatrics·P B HesselingS Moore
Feb 7, 2003·Journal of Pediatric Hematology/oncology·Eneida R NemecekJulie Park
May 30, 2003·The Oncologist·Joanna L WeinsteinSusan L Cohn
Jan 7, 2004·Journal of Pediatric Hematology/oncology·Brian H KushnerNai-Kong V Cheung
Dec 19, 2003·Expert Opinion on Pharmacotherapy·Victoria Castel, Adela Cañete
Oct 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard M KatzensteinMorris Kletzel
Aug 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W B LondonS L Cohn
Oct 17, 2007·Chemical Biology & Drug Design·Thilo S LangeLaurent Brard
Aug 1, 2008·Japanese Journal of Clinical Oncology·Etsuo KuniedaGen Nishimura
Dec 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hervé RubieJean Michon
Nov 23, 2010·JAAPA : Official Journal of the American Academy of Physician Assistants·Mark Stebbins
Jun 1, 2012·Critical Reviews in Clinical Laboratory Sciences·Cormac Owens, Meredith Irwin
Jul 17, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Wolfgang Peter FendlerThomas Pfluger
Sep 25, 2014·Pediatric Blood & Cancer·Mark A ApplebaumSusan L Cohn
Nov 12, 2014·Annual Review of Medicine·Chrystal U Louis, Jason M Shohet
Feb 6, 2017·Pediatric Blood & Cancer·Kathelijne KraalHeleen van der Pal
Nov 12, 2017·World Journal of Surgery·Katherin VollmerHenning Fiegel
Feb 13, 2018·Journal of the Egyptian National Cancer Institute·Hossam ElzomorMohamed Fawzy
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H J NickersonJ Lukens
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M MarisG M Brodeur
Jan 7, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A PerezJ N Lukens
Apr 16, 2002·British Journal of Cancer·H IkedaH Takamatsu
Jul 9, 2003·Journal of Pediatric Hematology/oncology·John M Maris, Robert P Castleberry
May 14, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Alberto Olaya-VargasCarlos Calderón Elvir
Feb 17, 2005·Pediatric Blood & Cancer·Caroline LaverdièreCharles A Sklar
Oct 1, 2010·The New England Journal of Medicine·David L BakerUNKNOWN Children’s Oncology Group
May 19, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Victoria CastelUNKNOWN Grupo Español de Neuroblastoma (SEOP)
May 25, 2010·Chemical Biology & Drug Design·Thilo S LangeLaurent Brard
Dec 3, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tom MonclairUNKNOWN INRG Task Force
Apr 25, 2012·Indian Journal of Pediatrics·Sushmita Nitin Bhatnagar, Yogesh Kumar Sarin
Oct 6, 2015·The Cochrane Database of Systematic Reviews·Bilgehan YalçinElvira C van Dalen
Dec 2, 2015·Oncology Letters·Youssef Al-TonbaryAhmad Darwish
Jul 1, 2020·Pediatric Dermatology·Emily S NyersLara Wine Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jennifer A LowSandra M Swain
The Lancet Oncology
Andrew D J PearsonChildren's Cancer and Leukaemia Group (CCLG formerly United Kingdom Children's Cancer Study Group)
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Howard M KatzensteinMorris Kletzel
© 2022 Meta ULC. All rights reserved